These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


296 related items for PubMed ID: 26629936

  • 1. CXCL12-CXCR4 Axis Promotes Proliferation, Migration, Invasion, and Metastasis of Ovarian Cancer.
    Guo Q, Gao BL, Zhang XJ, Liu GC, Xu F, Fan QY, Zhang SJ, Yang B, Wu XH.
    Oncol Res; 2014; 22(5-6):247-58. PubMed ID: 26629936
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Abortifacient metapristone (RU486 derivative) interrupts CXCL12/CXCR4 axis for ovarian metastatic chemoprevention.
    Zheng N, Chen J, Li T, Liu W, Liu J, Chen H, Wang J, Jia L.
    Mol Carcinog; 2017 Aug; 56(8):1896-1908. PubMed ID: 28277622
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CD40 signal regulates CXCR4 mediating ovarian carcinoma cell migration: implications for extrapelvic metastastic factors.
    Qu QX, Huang Q, Xu J, Duan LT, Zhu YB, Zhang XG.
    Oncol Res; 2013 Aug; 20(9):383-92. PubMed ID: 23924922
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of the LPA-mediated CXCL12-CXCR4 axis in the tumor proliferation, migration and invasion of ovarian cancer cell lines.
    Wang H, Liu W, Wei D, Hu K, Wu X, Yao Y.
    Oncol Lett; 2014 May; 7(5):1581-1585. PubMed ID: 24765180
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma.
    Kajiyama H, Shibata K, Terauchi M, Ino K, Nawa A, Kikkawa F.
    Int J Cancer; 2008 Jan 01; 122(1):91-9. PubMed ID: 17893878
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer.
    Mao TL, Fan KF, Liu CL.
    Gene Ther; 2017 Oct 01; 24(10):621-629. PubMed ID: 28753202
    [Abstract] [Full Text] [Related]

  • 16. [Effect of semaphorin4D gene silencing on malignant behavior of human ovarian cancer SKOV3 cells].
    Chen Y, Zhang L, Wu HJ, Liu WX, Hao Q.
    Zhonghua Zhong Liu Za Zhi; 2011 May 01; 33(5):324-30. PubMed ID: 21875458
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Functional interaction between peritoneal mesothelial cells and stem cells of ovarian yolk sac tumor (SC-OYST) in peritoneal dissemination.
    Mitsui H, Shibata K, Suzuki S, Umezu T, Mizuno M, Kajiyama H, Kikkawa F.
    Gynecol Oncol; 2012 Feb 01; 124(2):303-10. PubMed ID: 22040835
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.